Imatinib (STI571) is a multi-targeted receptor tyrosine kinase inhibitor that selectively inhibits the kinase activities of BCR/ABL, v-Abl, PDGFR, and c-kit with oral activity. Imatinib has antitumor activity for the treatment of chronic granulocytic leukemia.
Molecular Weight:
493.6
Purity:
>99.99%
CAS Number:
[152459-95-5]
Formula:
C29H31N7O
Target:
SARS-CoV|||PDGFR|||Bcr-Abl|||c-Kit|||Autophagy
T6230
* VAT and and shipping costs not included. Errors and price changes excepted